This inventor holds 20 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Antiparasitic Agents. Top assignee: Pfizer Corporation. Active years: 1990-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Margate, GB (1990 - 1992)
- New York, NY (US) (1995 - 1998)
- Westbrook, GB (1992 - 2002)
- Kent, GB (1997 - 2006)
- Sandwich, GB (1999 - 2009)
Company Filing History:
Years Active: 1990-2009
Areas of Expertise:
Title: Stephen Paul Gibson - Innovator in Antiparasitic and Therapeutic Compounds
Introduction
Stephen Paul Gibson is a prominent inventor based in Sandwich, Great Britain. With an impressive portfolio of 20 patents, he has significantly contributed to the field of pharmaceutical innovations, particularly in the development of antiparasitic agents and therapeutic compounds.
Latest Patents
Among his latest inventions, one of the noteworthy patents focuses on antiparasitic agents, which includes compounds of a specific formula (I) and their pharmaceutically acceptable salts. This invention highlights the potential applications of these compounds in fighting parasitic infections. Another significant patent involves 3-azabicyclo[3.1.0]hexane derivatives, designed as opiate binding agents. These compounds, detailed by formula (I) along with their salts and prodrugs, are targeted for use in treating conditions related to opioid mediation. The patent also elaborates on the processes for synthesizing these valuable substances.
Career Highlights
Stephen’s career is closely tied to Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer has enabled him to push the boundaries of pharmaceutical research and innovation, leading to groundbreaking advancements in drug development.
Collaborations
In his innovative endeavors, Stephen collaborates with esteemed colleagues like Christopher J. Dutton and Ivan Tommasini. Their combined expertise not only amplifies their research efforts but also enriches the overall output of innovative solutions within the company.
Conclusion
With a robust array of patents and a dedicated career at Pfizer Corporation, Stephen Paul Gibson exemplifies the spirit of innovation in the pharmaceutical industry. His contributions in developing antiparasitic agents and therapeutic compounds illustrate his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile